AASM announces finalists for first Sleep Medicine Disruptors Innovation Award

DARIEN, Ill. – Eight finalists will compete in November for the first Sleep Medicine Disruptors Innovation Award from the American Academy of Sleep Medicine (AASM). 

An expert panel of nine AASM members reviewed and scored 23 entries according to their novelty, practicality, and potential to improve sleep health and sleep care by solving a significant and widespread problem. The eight entries with the highest overall scores received an invitation to give a pitch presentation in Austin. 

Each finalist will compete for an award in one of two categories: diagnostics or therapeutics. The in-person and virtual attendees of Sleep Medicine Disruptors 2025 will select the two award winners. The finalists are: 

Innovation Award Finalists | Diagnostics 

• Anatomic polysomnogram by Bairitone Health 
• DormoVision X by Dormotech 
• SleepBreath-PD by Health Intelligence Lab 
• Onera Home PSG by Onera Technologies 

Innovation Award Finalists | Therapeutics 

• AD109 by Apnimed 
• Modius Sleep by Neurovalens 
• Nidra by Noctrix Health 
• PST-1 for Sleep Apnea by WhisperSom 

The award competition is part of Sleep Medicine Disruptors 2025, which will be held in person in Austin, Texas, and livestreamed Friday and Saturday, Nov. 14 – 15. 

In addition to nine featured lectures, the event will include the presentation of 25 abstracts during two poster sessions and oral presentation sessions. An exhibit hall will also feature products and services from leading companies in the industry. 

Sleep Medicine Disruptors will be held at the Austin Marriott Downtown at 304 E. Cesar Chavez St.  Registration information is available at aasm.org/disruptors.